Fisher & Paykel Healthcare logo

FPH - Fisher & Paykel Healthcare News Story

NZD33.8 -0.1  -0.3%

Last Trade - 6:00am

Large Cap
Market Cap £10.03bn
Enterprise Value £10.01bn
Revenue £825.8m
Position in Universe 31st / 1911

BUZZ-Jefferies initiates Fisher & Paykel Healthcare Aussie shares with "positive"

Fri 25th May, 2018 1:36am
** Jefferies initiates coverage on Australian shares of
medical device firm Fisher & Paykel Healthcare (FPH)  FPH.AX 
with "positive" recommendation, price target of A$13.02
    ** Aussie shares of FPH up as much as 0.8 pct to A$12.14
    ** FPH’s "compelling" industry positioning and clinically
significant "Optiflow" product, which enables respiratory
support, is hard to ignore - Jefferies
    ** Jefferies says competitors have some market presence, but
Optiflow’s "superior" design and clinical data provides it with
powerful competitive advantage
    ** FPH posted a record H1 operating revenue for its Hospital
product group in November, citing increasing adoption of
Optiflow nasal high flow therapy
    ** "Products in the Hospital group now make up 57% of the
company’s operating revenue," FPH said in its H1 results
    ** Jefferies adds that there is risk to upside to FPH's
guidance of NZ$185 mln-NZ$190 mln for FY18 NPAT, from a better
than expected flu season and customer re-stocking
    ** FPH, primarily listed in New Zealand  FPH.NZ , is due to
release its full-year results on May 28

© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.